Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Anti-Lymphotoxin - Pipeline Insight, 2024
... the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following ... Read More
-
ARDS - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and ARDS treatment guidelines. The assessment part of the report embraces in-depth ARDS commercial assessment and clinical assessment of the ARDS pipeline products from the pre-clinical ... Read More
-
Astrocytoma - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Astrocytoma treatment guidelines. The assessment part of the report embraces in-depth Astrocytoma commercial assessment and clinical assessment of the Astrocytoma pipeline products from the pre-clinical ... Read More
-
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2024
... Channel Blockers development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Molybdenum cofactor deficiency (MOCOD)emerging - Pipeline Insight, 2024
... the Molybdenum cofactor deficiency (MOCOD)emerging market. A detailed picture of the Molybdenum cofactor deficiency (MOCOD)emerging pipeline landscape is provided, which includes the disease overview and Molybdenum cofactor deficiency (MOCOD)emerging treatment guidelines. The assessment part of ... Read More
-
Potassium Channel Openers - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Anaplastic Thyroid Cancer - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Adenosine A3 Receptor Agonist - Pipeline Insight, 2024
... Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2024
... Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Allergic Bronchopulmonary Aspergillosis - Pipeline Insight, 2024
... Aspergillosis market. A detailed picture of the Allergic Bronchopulmonary Aspergillosis pipeline landscape is provided, which includes the disease overview and Allergic Bronchopulmonary Aspergillosis treatment guidelines. The assessment part of the report embraces in-depth Allergic Bronchopulmonary ... Read More
-
Long QT Syndrome Treatment Market – By Type (Type 1, Type 2, Type 3), Treatment (Medication, Surgical Procedures), Diagnosis (Tests, Electrocardiogram, Genetic Testing), Global Forecast (2024 – 2032)
... witness 6.8% CAGR between 2024 and 2032, driven by increased research and development efforts by leading companies in the field. Long QT Syndrome is a cardiac disorder characterized by abnormal heart rhythms, necessitating specialized treatment ... Read More
-
Adenosine A2A Receptor Agonist - Pipeline Insight, 2024
... Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Age Related Macular Degeneration - Pipeline Insight, 2024
... the Age Related Macular Degeneration market. A detailed picture of the Age Related Macular Degeneration pipeline landscape is provided, which includes the disease overview and Age Related Macular Degeneration treatment guidelines. The assessment part of ... Read More
-
Retinitis Pigmentosa (RP) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for RP. The treatment guidelines for RP have been well established globally. Roche’s Luxturna (voretigene neparvovec) dominate the RP market. Majority of RP pipeline assets are ... Read More
-
Precision medicine Market Assessment, By Use [Diagnostics, Therapeutics], By Application [Central Nervous System, Respiratory, Immunology, Oncology, Others], By Technology [Point-of-care Testing, Stem Cell Therapy, Pharmacogenomics, Pharmacoproteomics, Others], By End-user [Pharmaceutical Companies, Diagnostic Companies, Healthcare IT Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Companies, Others], By Region, Opportunities and Forecast, 2017-2031F The global precision medicine market is projected to witness a CAGR of 9.73% during the forecast period 2024-2031, growing from USD 51.69 billion in 2023 to USD ... Read More
-
Peripheral Artery Disease (PAD): Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for PAD. The innovator marketed drugs space for PAD includes coagulation factor X inhibitors, fibrinogen activators, hepatocyte growth factor activators, and vascular endothelial growth factor activators, ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape
... 2024 in the 16 countries covered in GlobalData’s epidemiology forecast for FECD. Currently there are no FDA approved therapies for FECD. The most recent guideline for FECD was developed by the American Academy of Ophthalmology. ... Read More
-
Scaffold Technology Market, By Material Type (Natural, Synthetic, Bio-ceramics, Biodegradable Metals, Carbon-based Nanomaterials), By Printing Technology (Bioprinting, 3D Printing, Selective Laser Sintering, Stereolithography, Thermal-Induced Phase Separation Method, Others), By Application (Tissue Engineering, Stem Cell Research, Drug Development & Discovery, Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Drug Development & Discovery, Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Scaffold technology is a ... Read More
-
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
... participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been ... Read More
-
Global Postmenopausal Vaginal Atrophy Drugs Market Growth 2024-2030
... downstream market, the Postmenopausal Vaginal Atrophy Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Meningococcal Vaccines Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Difficulties in R&D Introduction of vaccine requires immense amount of ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - ... Read More
-
Klebsiella Pneumoniae Infections - Epidemiology Forecast - 2034
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2020-2034 Klebsiella Pneumoniae ... Read More
-
Global Drug Discovery Outsourcing Market 2024-2028
... drug discovery outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Antipsychotic Drugs Market Size Study & Forecast, by Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030
... Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030 Global Antipsychotic Drugs Market is valued approximately at USD 15.47 billion in 2022 and ... Read More
Research Assistance
